HelioLiver LDT now available to order through Quest Diagnostics
A person standing in a golden field at sunset
News & Media

Mission to Offer Cancer Screenings for Firefighters

Media Coverage Apr 13, 2018 5 min read City of Mission, TX
Share

The City of Mission, Texas, authorized IvyGene blood tests — from the Laboratory for Advanced Medicine (now Helio Genomics) — to screen its firefighters for colon, liver, and lung cancer.

The City of Mission, Texas, authorized the purchase of IvyGene tests — a blood test developed by the Laboratory for Advanced Medicine (LAM), the company that would become Helio Genomics — to screen its firefighters for the presence of certain cancers, including colon, liver and lung cancer.

“We’re doing this for the firefighters obviously because of their working environment and what they have to deal with every day.”

MGMartin GarzaCity Manager, City of Mission, Texas

The move followed the case of local firefighter Homer Salinas, and reflected a broader effort by the city to do more for its firefighters — who, under Texas law (Chapter 607 of the Texas Government Code), are presumed to have developed certain cancers as a result of their employment. The city arranged a discounted price of $375 per test for each of its 67 full-time firefighters who chose to participate, with tests overseen by a local physician, Dr. Mario Anzaldua. While the test can detect the presence of some cancers, it is not a diagnosis; if disease is detected, the physician makes a referral.

Read the Full Article

Source: City of Mission, Texas. Read the full article.

Related Articles

More from Helio Genomics

NewsMay 12, 2026

HelioLiver Expands Access Through Quest

Helio broadens access to HelioLiver through Quest Diagnostics’ nationwide network of patient service centers.

Read more
NewsMay 8, 2026

Collaborating with the Rural Health Transformation Collaborative, Co-Chaired by Microsoft

Helio joins the Rural Health Transformation Collaborative, co-chaired by Microsoft, to expand rural early detection.

Read more
VoicesMay 6, 2026

Bharat Tewarie: Giving Patients a “Real Fighting Chance” Against Liver Cancer

Helio’s CEO reflects on the landmark CLiMB study and what earlier liver cancer detection means for patients.

Read more